Home » Author Archive

Stephens Reaffirms Overweight Rating for Privia Health Group (NASDAQ:PRVA)

Posted by Matthew Jenks on Jan 4th, 2025

Privia Health Group (NASDAQ:PRVA – Get Free Report)‘s stock had its “overweight” rating restated by Stephens in a note issued to investors on Thursday,Benzinga reports. They currently have a $26.00 price target... More of this article »

89bio (NASDAQ:ETNB) Earns “Overweight” Rating from Cantor Fitzgerald

Posted by Matthew Jenks on Jan 4th, 2025

89bio (NASDAQ:ETNB – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a report issued on Thursday,Benzinga reports. They currently have a $29.00... More of this article »

Nuveen Preferred and Income Term Fund Declares Monthly Dividend of $0.17 (NYSE:JPI)

Posted by Matthew Jenks on Jan 4th, 2025

Nuveen Preferred and Income Term Fund (NYSE:JPI – Get Free Report) announced a monthly dividend on Thursday, January 2nd,Wall Street Journal reports. Stockholders of record on Wednesday, January 15th will be paid a dividend of... More of this article »

Tilly’s (NYSE:TLYS) Stock Passes Below Fifty Day Moving Average – Here’s What Happened

Posted by Matthew Jenks on Jan 3rd, 2025

Shares of Tilly’s, Inc. (NYSE:TLYS – Get Free Report) crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $3.95 and traded as low as $3.90. Tilly’s shares... More of this article »

Nascent Biotech (OTCMKTS:NBIO) Stock Crosses Below Fifty Day Moving Average – What’s Next?

Posted by Matthew Jenks on Jan 3rd, 2025

Nascent Biotech, Inc. (OTCMKTS:NBIO – Get Free Report)’s share price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.06 and traded as low as $0.05. Nascent... More of this article »